The scientific evidence for the role of milk protein-derived bioactive peptides in humans: A Review

Journal of Functional Foods

Volumn 17, Issue , 2015, Pages 640-656

  Nongonierma, Alice B ^a   FitzGerald, Richard J ^a  

^a UNIVERSITY OF LIMERICK   (Ireland)

Author keywords

Bioactive peptides; Bioavailability; Human studies; Milk

Indexed keywords

EID: 84938833523     PISSN: 17564646     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jff.2015.06.021     Document Type: Review

References (196)

1. Abdullah M., Cyr A., Labont M.-E., Lépine M.-C., Couture P., Eck P., Lamarche B., Jones P. The impact of dairy consumption on circulating cholesterol levels is modulated by common single nucleotide polymorphisms in cholesterol synthesis-and transport-related genes (1038.4). The FASEB Journal 2014, 28. 1038.1034.
2. Adel-Patient K., Nutten S., Bernard H., Fritsché R., Ah-Leung S., Meziti N., Prioult G., Mercenier A., Wal J.-M. Immunomodulatory potential of partially hydrolyzed β-lactoglobulin and large synthetic peptides. Journal of Agricultural and Food Chemistry 2012, 60:10858-10866.
3. Adel-Patient K., Wavrin S., Bernard H., Meziti N., Ah-Leung S., Wal J.M. Oral tolerance and Treg cells are induced in BALB/c mice after gavage with bovine β-lactoglobulin. Allergy 2011, 66:1312-1321.
4. Adolphi B., Scholz-Ahrens K.E., de Vrese M., Açil Y., Laue C., Schrezenmeir J. Short-term effect of bedtime consumption of fermented milk supplemented with calcium, inulin-type fructans and caseinphosphopeptides on bone metabolism in healthy, postmenopausal women. European Journal of Nutrition 2009, 48:45-53.
5. Agyei D., Danquah M.K. Rethinking food-derived bioactive peptides for antimicrobial and immunomodulatory activities. Trends in Food Science & Technology 2012, 23:62-69.
6. Ait-Oukhatar N., Peres J.M., Bouhallab S., Neuville D., Bureau F., Bouvard G., Arhan P., Bougle D. Bioavailability of caseinophosphopeptide-bound iron. The Journal of Laboratory and Clinical Medicine 2002, 140:290-294.
7. Akhavan T., Luhovyy B.L., Brown P.H., Cho C.E., Anderson G.H. Effect of premeal consumption of whey protein and its hydrolysate on food intake and postmeal glycemia and insulin responses in young adults. The American Journal of Clinical Nutrition 2010, 91:966-975.
8. Altenburger M.J., Gmeiner B., Hellwig E., Wrbas K.-T., Schirrmeister J.F. The evaluation of fluorescence changes after application of casein phosphopeptides (CPP) and amorphous calcium phosphate (ACP) on early carious lesions. American Journal of Dentistry 2010, 23:188-192.
9. Anderson G.H., Moore S.E. Dietary proteins in the regulation of food intake and body weight in humans. The Journal of Nutrition 2004, 134:974S-979S.
10. Artym J., Zimecki M. Milk-derived proteins and peptides in clinical trials. Postȩpy higieny i medycyny doświadczalnej (Online) 2013, 67:800-816.
11. Azarpazhooh A., Limeback H. Clinical efficacy of casein derivatives. A systematic review of the literature. The Journal of American Dental Association 2008, 139:915-924.
12. Baguet J., Legallicier B., Auquier P., Robitail S. Updated meta-analytical approach to the efficacy of antihypertensive drugs in reducing blood pressure. Clinical Drug Investigation 2007, 27:735-753.
13. Ballard K.D., Kupchak B.R., Volk B.M., Mah E., Shkreta A., Liptak C., Ptolemy A.S., Kellogg M.S., Bruno R.S., Seip R.L. Acute effects of ingestion of a novel whey-derived extract on vascular endothelial function in overweight, middle-aged men and women. British Journal of Nutrition 2013, 109:882-893.
14. Barbé F., Le Feunteun S., Rémond D., Ménard O., Jardin J., Henry G., Laroche B., Dupont D. Tracking the in vivo release of bioactive peptides in the gut during digestion: Mass spectrometry peptidomic characterization of effluents collected in the gut of dairy matrix fed mini-pigs. Food Research International 2014, 63(PartB):147-156.
15. Barbosa C.M.S., Morais H.A., Delvivo F.M., Mansur H.S., De Oliveira M.C., Silvestre M.P.C. Papain hydrolysates of casein: Molecular weight profile and encapsulation in lipospheres. Journal of the Science of Food and Agriculture 2004, 84:1891-1900.
16. Beerens M.W., van der Veen M.H., van Beek H., ten Cate J.M. Effects of casein phosphopeptide amorphous calcium fluoride phosphate paste on white spot lesions and dental plaque after orthodontic treatment: A 3-month follow-up. European Journal of Oral Sciences 2010, 118:610-617.
17. Bendtsen L.Q., Lorenzen J.K., Bendsen N.T., Rasmussen C., Astrup A. Effect of dairy proteins on appetite, energy expenditure, body weight, and composition: A review of the evidence from controlled clinical trials. Advances in Nutrition: An International Review Journal 2013, 4:418-438.
18. Benkerroum N. Antimicrobial peptides generated from milk proteins: A survey and prospects for application in the food industry. A review. International Journal of Dairy Technology 2010, 63:320-338.
19. Berg A. The role of hydrolysates for allergy prevention-pro. Pediatric Allergy and Immunology 2013, 24:720-723.
20. Bernabucci U., Nardone A. Milk proteins: Source of bioactive peptides to human health ATTI. http://www.arnaweb.org/arna2014/assets/documents/Atti%20Convegno%20ARNA%202014.pdf#page=9.
21. Bernard B.K., Nakamura Y., Bando I., Mennear J.H. Studies of the toxicological potential of tripeptides (L-valyl-L-prolyl-L-proline and L-isoleucyl-L-prolyl-L-proline): II. Introduction. International Journal of Toxicology 2005, 24:5-11.
22. Bouhallab S., Bouglé D. Biopeptides of milk: Caseinophosphopeptides and mineral bioavailability. Reproduction, Nutrition, Development 2004, 44:493-498.
23. Boutrou R., Gaudichon C., Dupont D., Jardin J., Airinei G., Marsset-Baglieri A., Benamouzig R., Tomé D., Leonil J. Sequential release of milk protein-derived bioactive peptides in the jejunum in healthy humans. The American Journal of Clinical Nutrition 2013, 97:1314-1323.
24. Boutrou R., Henry G., Sanchez-Rivera L. On the trail of milk bioactive peptides in human and animal intestinal tracts during digestion: A review. Dairy Science & Technology 2015, 1-15. Published online. 10.1007/s13594-015-0210-0.
25. Brayden D.J., Baird A.W. Opportunities for drug-delivery research in nutraceuticals and functional foods?. Therapeutic Delivery 2013, 4:301-305.
26. Brochner A., Christensen C., Kristensen B., Tranaeus S., Karlsson L., Sonnensen L., Twetman S. Treatment of post-orthodontic white spot lesions with casein phosphopeptide-stabilised amorphous calcium phosphate. Clinical Oral Investigations 2011, 15:369-373.
27. Brouwer C.P.J.M., Rahman M., Welling M.M. Discovery and development of a synthetic peptide derived from lactoferrin for clinical use. Peptides 2011, 32:1953-1963.
28. Burton-Freeman B.M. Glycomacropeptide (GMP) is not critical to whey-induced satiety, but may have a unique role in energy intake regulation through cholecystokinin (CCK). Physiology & Behavior 2008, 93:379-387.
29. Carrasco-Castilla J., Hernández-Álvarez A.J., Jiménez-Martínez C., Gutiérrez-López G.F., Dávila-Ortiz G. Use of proteomics and peptidomics methods in food bioactive peptide science and engineering. Food Engineering Reviews 2012, 4:224-243.
30. Caruana P.C., Al Mulaify S., Moazzez R., Bartlett D. The effect of casein and calcium containing paste on plaque pH following a subsequent carbohydrate challenge. Journal of Dentistry 2009, 37:522-526.
31. Chabance B., Jollès P., Izquierdo C., Mazoyer E., Francoual C., Drouet L., Fiat A.-M. Characterization of an antithrombotic peptide from α-casein in newborn plasma after milk ingestion. British Journal of Nutrition 1995, 73:583-590.
32. Chabance B., Marteau P., Rambaud J., Migliore-Samour D., Boynard M., Perrotin P., Guillet R., Jolles P., Fiat A. Casein peptide release and passage to the blood in humans during digestion of milk or yogurt. Biochimie 1998, 80:155-165.
33. Chatterton D.E., Smithers G., Roupas P., Brodkorb A. Bioactivity of β-lactoglobulin and α-lactalbumin - technological implications for processing. International Dairy Journal 2006, 16:1229-1240.
34. Chungchunlam S.M.S., Henare S.J., Ganesh S., Moughan P.J. Effect of whey protein and glycomacropeptide on measures of satiety in normal-weight adult women. Appetite 2014, 78:172-178.
35. Cicero A.F., Aubin F., Azais-Braesco V., Borghi C. Do the lactotripeptides isoleucine-proline-proline and valine-proline-proline reduce systolic blood pressure in European subjects? A meta-analysis of randomized controlled trials. American Journal of Hypertension 2013, 26:442-449.
36. Cicero A., Gerocarni B., Laghi L., Borghi C. Blood pressure lowering effect of lactotripeptides assumed as functional foods: A meta-analysis of current available clinical trials. Journal of Human Hypertension 2011, 25:425-436.
37. Clare D.A., Swaisgood H.E. Bioactive milk peptides: A prospectus. Journal of Dairy Science 2000, 83:1187-1195.
38. Clemente A. Enzymatic protein hydrolysates in human nutrition. Trends in Food Science & Technology 2000, 11:254-262.
39. Cogan U., Moshe M., Mokady S. Debittering and nutritional upgrading of enzymic casein hydrolysates. Journal of the Science of Food and Agriculture 1981, 32:459-466.
40. Cross K.J., Huq N.L., O'Brien-Simpson M., Perich J.W., Attard T.J., Reynolds E.C. The role of multiphosphoserylated peptides in mineralised tissue regeneration. International Journal of Peptide Research and Therapeutics 2007, 13:479-495.
41. Cross K.J., Huq N.L., Reynolds E.C. Casein phosphopeptides in oral health - Chemistry and clinical applications. Current Pharmaceutical Design 2007, 13:793-800.
42. de Vos P., Faas M.M., Spasojevic M., Sikkema J. Encapsulation for preservation of functionality and targeted delivery of bioactive food components. International Dairy Journal 2010, 20:292-302.
43. Dave L.A., Montoya C.A., Rutherfurd S.M., Moughan P.J. Gastrointestinal endogenous proteins as a source of bioactive peptides-An in silico study. PLoS ONE 2014, 9:e98922. 10.1371/journal.pone.0098922.
44. De Noni I., FitzGerald R.J., Korhonen H.J., Le Roux Y., Livesey C.T., Thorsdottir I., Tomé D., Witkamp R. Review of the potential health impact of β-casomorphins and related peptides. EFSA Scientific Report 2009, 231:1-107.
45. EFSA Scientific opinion on the substantiation of health claims related to a C12 peptide (Phe-Phe-Val-Ala-Pro-Phe-Pro-Glu-Val-Phe-Gly-Lys) and maintenance of normal blood pressure (ID 1483, 3130) pursuant to Article 13 (1) of Regulation (EC) No 1924/2006: EFSA-Q-2008-2220, EFSA-Q-2008-3862. European Food Safety Authority Journal 2010, 8:1478-1489. http://www.efsa.europa.eu/en/scdocs/doc/1478.pdf.
46. EFSA Scientific opinion on the substantiation of a health claim related to isoleucyl-prolyl-proline (IPP) and valyl-prolyl-proline (VPP) and maintenance of normal blood pressure pursuant to Article 13(5) of Regulation (EC) No 1924/2006. European Food Safety Authority Journal 2011, 9:2380-2397. http://dx.doi.org/10.2903/j.efsa.2011.2380.
47. Elliott R., Harris D., Hill J., Bibby N., Wasmuth H. Type I (insulin-dependent) diabetes mellitus and cow milk: Casein variant consumption. Diabetologia 1999, 42:292-296.
48. s1-casein using extensively purified synthetic peptides. Scandinavian Journal of Immunology 2004, 60:486-493.
49. Erba D., Ciappellano S., Testolin G. Effect of the ratio of casein phosphopeptides to calcium (w/w) on passive calcium transport in the distal small intestine of rats. Nutrition (Burbank, Los Angeles County, Calif.) 2002, 18:743-746.
50. Favaro-Trindade C.S., Santana A.S., Monterrey-Quintero E.S., Trindade M.A., Netto F.M. The use of spray drying technology to reduce bitter taste of casein hydrolysate. Food Hydrocolloids 2010, 24:336-340.
51. Fekete Á.A., Givens D.I., Lovegrove J.A. Casein-derived lactotripeptides reduce systolic and diastolic blood pressure in a meta-analysis of randomised clinical trials. Nutrients 2015, 7:659-681.
52. Fekete A.A., Givens D.I., Lovegrove J.A. The impact of milk proteins and peptides on blood pressure and vascular function: A review of evidence from human intervention studies. Nutrition Research Reviews 2013, 26:177-190.
53. Fernández-Musoles R., Salom J.B., Castelló-Ruiz M., Contreras M.D.M., Recio I., Manzanares P. Bioavailability of antihypertensive lactoferricin B-derived peptides: Transepithelial transport and resistance to intestinal and plasma peptidases. International Dairy Journal 2013, 32:169-174.
54. FitzGerald R.J. Potential uses of caseinophosphopeptides. International Dairy Journal 1998, 8:451-457.
55. FitzGerald R.J., Meisel H. Caseinphosphopeptides (CPPs) as functional ingredients. Functional dairy products 2003, 187-202. Woodhead Publishing Ltd, Cambridge, UK. T. Mattila-Sandholm, M. Saarela (Eds.).
56. FitzGerald R.J., Meisel H. Milk protein hydrolysates and bioactive peptides. Advanced dairy chemistry-1 proteins 2003, 675-698. Kluwer Academic/Plenum Publishers, New-York. P.F. Fox, P. McSweeney (Eds.).
57. Flint H.J., Scott K.P., Louis P., Duncan S.H. The role of the gut microbiota in nutrition and health. Nature Reviews. Gastroenterology and Hepatology 2012, 9:577-589.
58. Foltz M., Meynen E.E., Bianco V., van Platerink C., Koning T.M.M.G., Kloek J. Angiotensin converting enzyme inhibitory peptides from a lactotripeptide-enriched milk beverage are absorbed intact into the circulation. The Journal of Nutrition 2007, 137:953-958.
59. Frid A.H., Nilsson M., Holst J.J., Björck I.M. Effect of whey on blood glucose and insulin responses to composite breakfast and lunch meals in type 2 diabetic subjects. The American Journal of Clinical Nutrition 2005, 82:69-75.
60. Froetschel M., Azain M., Edwards G., Barb C., Amos H. Opioid and cholecystokinin antagonists alleviate gastric inhibition of food intake by premeal loads of casein in meal-fed rats. The Journal of Nutrition 2001, 131:3270-3276.
61. García-Tejedor A., Sánchez-Rivera L., Castelló-Ruiz M., Recio I., Salom J.B., Manzanares P. Novel antihypertensive lactoferrin-derived peptides produced by Kluyveromyces marxianus: Gastrointestinal stability profile and in vivo angiotensin I-converting enzyme (ACE) inhibition. Journal of Agricultural and Food Chemistry 2014, 62:1609-1616.
62. Gardner M.L.G. Entry of peptides of dietary origin into the circulation. Nutrition and Health 1983, 2:163-171.
63. Gaudel C., Nongonierma A.B., Maher S., Flynn S., Murray B.A., Kelly P.M., Krause M., FitzGerald R.J., Newsholme P. A whey protein hydrolysate promotes insulinotropic activity in a clonal pancreatic β-cell line and enhances glycemic function in ob/ob mice. The Journal of Nutrition 2013, 143:1109-1114.
64. Gauthier S.F., Pouliot Y., Saint-Sauveur D. Immunomodulatory peptides obtained by the enzymatic hydrolysis of whey proteins. International Dairy Journal 2006, 16:1315-1323.
65. Geerts B.F., van Dongen M.G.J., Flameling B., Moerland M.M., de Kam M.L., Cohen A.F., Romijn J.A., Gerhardt C.C., Kloek J., Burggraaf J. Hydrolyzed casein decreases postprandial glucose concentrations in T2DM patients irrespective of leucine content. Journal of Dietary Supplements 2011, 8:280-292.
66. Goudarzi M., Madadlou A. Influence of whey protein and its hydrolysate on prehypertension and postprandial hyperglycaemia in adult men. International Dairy Journal 2013, 33:62-66.
67. Gueguen L., Pointillart A. The bioavailability of dietary calcium. The Journal of American College of Nutrition 2000, 10:119S-136S.
68. Guilloteau P., Romé V., Delaby L., Mendy F., Roger L., Chayvialle J.A. Is caseinomacropeptide from milk proteins, an inhibitor of gastric secretion?. Regulatory Peptides 2010, 159:129-136.
69. Gupta R., Prakash V. CPP-ACP complex as a new adjunctive agent for remineralisation: A review. Oral Health and Preventive Dentistry 2011, 9:151-165.
70. Gustafson D.R., McMahon D.J., Morrey J., Nan R. Appetite is not influenced by a unique milk peptide: Caseinomacropeptide (CMP). Appetite 2001, 36:157-163.
71. Hansen M., Sandström B., Jensen M., Sørensen S.S. Casein phosphopeptides improve zinc and calcium absorption from rice-based but not from whole-grain infant cereal. Journal of Pediatric Gastroenterology and Nutrition 1997, 24:56-62.
72. Hartmann R., Meisel H. Food-derived peptides with biological activity: From research to food applications. Current Opinion in Biotechnology 2007, 18:163-169.
73. Heaney R.P., Saito Y., Orimo H. Effect of caseinphosphopeptide on absorbability of co-ingested calcium in normal postmenopausal women. Journal of Bone and Mineral Metabolism 1994, 12:77-81.
74. Hernández-Ledesma B., García-Nebot M.J., Fernández-Tomé S., Amigo L., Recio I. Dairy protein hydrolysates: Peptides for health benefits. International Dairy Journal 2014, 38:82-100.
75. Iwaniak A., Minkiewicz P., Darewicz M., Protasiewicz M., Mogut D. Chemometrics and cheminformatics in the analysis of biologically active peptides from food sources. Journal of Functional Foods 2015, 16:334-351.
76. Jahan-Mihan A., Luhovyy B.L., El Khoury D., Anderson G.H. Dietary proteins as determinants of metabolic and physiologic functions of the gastrointestinal tract. Nutrients 2011, 3:574-603.
77. Jauhiainen T., Pilvi T., Cheng Z.J., Kautiainen H., Ller D.N., Vapaatalo H., Korpela R., Mervaala E. Milk products containing bioactive tripeptides have an antihypertensive effect in double transgenic rats (dTGR) harbouring human renin and human angiotensinogen genes. Journal of Nutrition and Metabolism 2009, 2010:1-6.
78. Jauhiainen T., Ronnback M., Vapaatalo H., Wuolle K., Kautiainen H., Groop P.H., Korpela R. Long-term intervention with Lactobacillus helveticus fermented milk reduces augmentation index in hypertensive subjects. European Journal of Clinical Nutrition 2010, 64:424-431.
79. Jauhiainen T., Wuolle K., Vapaatalo H., Kerojoki O., Nurmela K., Lowrie C., Korpela R. Oral absorption, tissue distribution and excretion of a radiolabelled analog of a milk-derived antihypertensive peptide, Ile-Pro-Pro, in rats. International Dairy Journal 2007, 17:1216-1223.
80. Jäkälä P., Vapaatalo H. Antihypertensive peptides from milk proteins. Pharmaceuticals 2010, 3:251-272.
81. Jonker J.T., Wijngaarden M.A., Kloek J., Groeneveld Y., Gerhardt C., Brand R., Kies A.K., Romijn J.A., Smit J.W.A. Effects of low doses of casein hydrolysate on post-challenge glucose and insulin levels. European Journal of Internal Medicine 2011, 22:245-248.
82. Kamiński S., Cieślińska A., Kostyra E. Polymorphism of bovine beta-casein and its potential effect on human health. Journal of Applied Genetics 2007, 48:189-198.
83. Kasai T., Iwasaki R., Tanaka M., Kiriyama S. Caseinphosphopeptides (CPP) in feces and contents in digestive tract of rats fed casein and CPP preparations. Bioscience, Biotechnology, and Biochemistry 1995, 59:26-30.
84. Keogh J.B., Woonton B.W., Taylor C.M., Janakievski F., Desilva K., Clifton P.M. Effect of glycomacropeptide fractions on cholecystokinin and food intake. British Journal of Nutrition 2010, 104:286-290.
85. Kitamura H., Otani H. Fecal IgA levels in healthy persons who ingested cakes with or without bovine casein phosphopeptides. Milchwissenschaft 2002, 57:611-614.
86. Kitasako Y., Cochrane N.J., Khairul M., Shida K., Adams G.G., Burrow M.F., Reynolds E.C., Tagami J. The clinical application of surface pH measurements to longitudinally assess white spot enamel lesions. Journal of Dentistry 2010, 38:584-590.
87. Kitts D.D. Antioxidant properties of casein-phosphopeptides. Trends in Food Science & Technology 2005, 16:549-554.
88. Koch G., Wiedemann K., Drebes E., Zimmermann W., Link G., Teschemacher H. Human β-casomorphin-8 immunoreactive material in the plasma of women during pregnancy and after delivery. Regulatory Peptides 1988, 20:107-117.
89. Koopman R., Crombach N., Gijsen A.P., Walrand S., Fauquant J., Kies A.K., Lemosquet S., Saris W.H., Boirie Y., van Loon L.J. Ingestion of a protein hydrolysate is accompanied by an accelerated in vivo digestion and absorption rate when compared with its intact protein. The American Journal of Clinical Nutrition 2009, 90:106-115.
90. Korhonen H., Pihlanto A. Bioactive peptides: Production and functionality. International Dairy Journal 2006, 16:945-960.
91. Kost N.V., Sokolov O.Y., Kurasova O.B., Dmitriev A.D., Tarakanova J.N., Gabaeva M.V., Zolotarev Y.A., Dadayan A.K., Grachev S.A., Korneeva E.V., Mikheeva I.G., Zozulya A.A. β-Casomorphins-7 in infants on different type of feeding and different levels of psychomotor development. Peptides 2009, 30:1854-1860.
92. Lacroix I.M.E., Li-Chan E.C.Y. Overview of food products and dietary constituents with antidiabetic properties and their putative mechanisms of action: A natural approach to complement pharmacotherapy in the management of diabetes. Molecular Nutrition & Food Research 2014, 58:61-78.
93. Lalor F., Wall P.G. Making and justifying health claims. International Journal of Dairy Technology 2013, 66:321-324.
94. Laugesen M., Elliott R. Ischaemic heart disease, Type 1 diabetes, and cow milk A1 β-casein. The New Zealand Medical Journal 2003, 116:1-19.
95. Law M., Morris J., Wald N. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: Meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. British Medical Journal 2009, 338:1-19.
96. Le Maux S., Nongonierma A.B., FitzGerald R.J. Improved short peptide identification using HILIC-MS/MS: Retention time prediction model based on the impact of amino acid position in the peptide sequence. Food Chemistry 2015, 175:847-854.
97. Ledoux N., Mahe S., Dubarry M., Bourras M., Benamouzig R., Tome D. Intraluminal immunoreactive caseinomacropeptide after milk protein ingestion in humans. Food/Nahrung 1999, 43:196-200.
98. Li-Chan E.C. Bioactive peptides and protein hydrolysates: Research trends and challenges for application as nutraceuticals and functional food ingredients. Current Opinion in Food Science 2015, 1:28-37.
99. López-Bajonero L.J., Lara-Calderón P., Gálvez-Mariscal A., Velazques-Arellano A., López-Munguia A. Enzymatic production of a low-phenylalanine product from skim milk powder and caseinate. Journal of Food Science 1991, 56:938-942.
100. López-Huertas E., Teucher B., Boza J.J., Martínez-Férez A., Majsak-Newman G., Baró L., Carrero J.J., González-Santiago M., Fonollá J., Fairweather-Tait S. Absorption of calcium from milks enriched with fructo-oligosaccharides, caseinophosphopeptides, tricalcium phosphate, and milk solids. The American Journal of Clinical Nutrition 2006, 83:310-316.
101. Lollo P.C.B., Amaya-Farfan J., Faria I.C., Salgado J.V.V., Chacon-Mikahil M.P.T., Cruz A.G., Oliveira C.A.F., Montagner P.C., Arruda M. Hydrolysed whey protein reduces muscle damage markers in Brazilian elite soccer players compared with whey protein and maltodextrin. A twelve-week in-championship intervention. International Dairy Journal 2014, 34:19-24.
102. Luhovyy B.L., Akhavan T., Anderson G.H. Whey proteins in the regulation of food intake and satiety. Journal of the American College of Nutrition 2007, 26:704S-712S.
103. Maeno M., Nakamura Y., Mennear J.H., Bernard B.K. Studies of the toxicological potential of tripeptides (L-valyl-L-prolyl-L-proline and L-isoleucyl-L-prolyl-L-proline): III. Single-and/or repeated-dose toxicity of tripeptides containing Lactobacillus helveticus-fermented milk powder and casein hydrolysate in rats. International Journal of Toxicology 2005, 24:13-23.
104. Maher S., Brayden D.J. Overcoming poor permeability: Translating permeation enhancers for oral peptide delivery. Drug Discovery Today: Technologies 2012, 9:e113-e119.
105. Mandal S.M., Bharti R., Porto W.F., Gauri S.S., Mandal M., Franco O.L., Ghosh A.K. Identification of multifunctional peptides from human milk. Peptides 2014, 56:84-93.
106. Manders R.J., Hansen D., Zorenc A.H., Dendale P., Kloek J., Saris W.H., van Loon L.J. Protein co-ingestion strongly increases postprandial insulin secretion in type 2 diabetes patients. Journal of Medicinal Food 2014, 17:758-763.
107. Manders R.J., Koopman R., Sluijsmans W.E., van den Berg R., Verbeek K., Saris W.H., Wagenmakers A.J., van Loon L.J. Co-ingestion of a protein hydrolysate with or without additional leucine effectively reduces postprandial blood glucose excursions in Type 2 diabetic men. The Journal of Nutrition 2006, 136:1294-1299.
108. Manders R.J., Praet S.F.E., Meex R.C.R., Koopman R., de Roos A.L., Wagenmakers A.J.M., Saris W.H.M., van Loon L.J.C. Protein hydrolysate/leucine ingestion reduces the prevalence of hyperglycemia in Type 2 diabetic patients. Diabetes Care 2006, 29:2721-2722.
109. Manders R.J., Praet S.F.E., Vikstrom M.H., Saris W.H.M., van Loon L.J.C. Protein hydrolysate co-ingestion does not modulate 24 h glycemic control in long-standing type 2 diabetes patients. European Journal of Clinical Nutrition 2007, 63:121-126.
110. Manders R.J., Wagenmakers A.J., Koopman R., Zorenc A.H., Menheere P.P., Schaper N.C., Saris W.H., van Loon L.J. Co-ingestion of a protein hydrolysate and amino acid mixture with carbohydrate improves plasma glucose disposal in patients with type 2 diabetes. The American Journal of Clinical Nutrition 2005, 82:76-83.
111. ® products. International Journal of Dental Hygiene 2010, 8:232-236.
112. McGregor R.A., Poppitt S.D. Milk protein for improved metabolic health: A review of the evidence. Nutrition & Metabolism 2013, 10:46.
113. Meisel H., Fairweather-Tait S., FitzGerald R.J., Hartmann R., Lane C.N., McDonagh D., Teucher B., Wal J.M. Detection of caseinophosphopeptides in the distal ileostomy fluid of human subjects. British Journal of Nutrition 2003, 89:351-359.
114. Meisel H., FitzGerald R.J. Biofunctional peptides from milk proteins: Mineral binding and cytomodulatory effects. Current Pharmaceutical Design 2003, 9:1289-1295.
115. Meisel H., Frister H. Chemical characterization of a caseinophosphopeptide isolated from in vivo digests of a casein diet. Biological Chemistry Hoppe-Seyler 1988, 369:1275-1279.
116. Morais H.A., Da Silva Barbosa C.M., Delvivo F.M., Mansur H.S., Cristina De Oliveira M., Silvestre M.P.C. Comparative study of microencapsulation of casein hydrolysates in lipospheres and liposomes. Journal of Food Biochemistry 2004, 28:21-41.
117. Morifuji M., Ishizaka M., Baba S., Fukuda K., Matsumoto H., Koga J., Kanegae M., Higuchi M. Comparison of different sources and degrees of hydrolysis of dietary protein: Effect on plasma amino acids, dipeptides, and insulin responses in human subjects. Journal of Agricultural and Food Chemistry 2010, 58:8788-8797.
118. Morris P.E., FitzGerald R.J. Whey proteins and peptides in human health. Whey processing, functionality and health benefits 2009, 285-343. Wiley-Blackwell. C. Onwulata, P. Huth (Eds.).
119. Moughan P.J., Rutherfurd S.M., Montoya C.A., Dave L.A. Food-derived bioactive peptides-a new paradigm. Nutrition Research Reviews 2013, 27:16-20.
120. Nakamura T., Aizawa T., Kariya R., Okada S., Demura M., Kawano K., Makabe K., Kuwajima K. Molecular mechanisms of the cytotoxicity of human α-lactalbumin made lethal to tumor cells (HAMLET) and other protein-oleic acid complexes. The Journal of Biological Chemistry 2013, 288:14408-14416.
121. Narva M., Karkkainen M., Poussa T., Lamberg-Allardt C., Korpela R. Caseinphosphopeptides in milk and fermented milk do not affect calcium metabolism acutely in postmenopausal women. Journal of the American College of Nutrition 2003, 22:88-93.
122. Newsholme P., Gaudel C., McClenaghan N. Nutrient regulation of insulin secretion and β-cell functional integrity. The Islets of Langerhans 2010, Vol. 654:91-114. Springer, The Netherlands.
123. Ney D.M., Gleason S.T., Calcar S.C., MacLeod E.L., Nelson K.L., Etzel M.R., Rice G.M., Wolff J.A. Nutritional management of PKU with glycomacropeptide from cheese whey. Journal of Inherited Metabolic Disease 2009, 32:32-39.
124. Nguyen N., Champion J., Ponce J., Quebbemann B., Patterson E., Pham B., Raum W., Buchwald J., Segato G., Favretti F. A review of unmet needs in obesity management. Obesity Surgery 2012, 22:956-966.
125. Nongonierma A.B., FitzGerald R.J. Enzymes exogenous to milk in dairy technology | proteinases. Encyclopedia of dairy sciences 2011, 289-296. Academic Press, San Diego. 2nd ed. J.W. Fuquay (Ed.).
126. Nongonierma A.B., FitzGerald R.J. Biofunctional properties of caseinophosphopeptides in the oral cavity. Caries Research 2012, 46:234-267.
127. Nongonierma A.B., FitzGerald R.J. Dipeptidyl peptidase IV inhibitory properties of a whey protein hydrolysate: Influence of fractionation, stability to simulated gastrointestinal digestion and food-drug interaction. International Dairy Journal 2013, 32:33-39.
128. Nongonierma A.B., FitzGerald R.J. Utilisation of the isobole methodology to study dietary peptide-drug and peptide-peptide interactive effects on dipeptidyl peptidase IV (DPP-IV) inhibition. Food & Function 2015, 6:312-319.
129. Norheim F., Gjelstad I.M., Hjorth M., Vinknes K.J., Langleite T.M., Holen T., Jensen J., Dalen K.T., Karlsen A.S., Kielland A. Molecular nutrition research - The modern way of performing nutritional science. Nutrients 2012, 4:1898-1944.
130. Norris R., FitzGerald R.J. Antihypertensive peptides from food proteins. Bioactive food peptides in health and disease 2013, 46-72. In Tech. B. Hernández-Ledesma (Ed.).
131. Nurminen M.-L., Sipola M., Kaarto H., Pihlanto-Leppälä A., Piilola K., Korpela R., Tossavainen O., Korhonen H., Vapaatalo H. α-Lactorphin lowers blood pressure measured by radiotelemetry in normotensive and spontaneously hypertensive rats. Life Sciences 2000, 66:1535-1543.
132. Nyberg F., Lieberman H., Lindström L., Lyrenäs S., Koch G., Terenius L. Immunoreactive β-casomorphin-8 in cerebrospinal fluid from pregnant and lactating women: Correlation with plasma levels. The Journal of Clinical Endocrinology & Metabolism 1989, 68:283-289.
133. Onwulata C.I. Microencapsulation and functional bioactive foods. Journal of Food Processing and Preservation 2012, 37:510-532.
134. Oseguera-Toledo M., González de Mejía E., Reynoso-Camacho R., Cardador-Martínez A., Amaya-Llano S. Proteins and bioactive peptides. Nutrafoods 2014, 13:147-157.
135. Panagiotakos D.B., Pitsavos C.H., Zampelas A.D., Chrysohoou C.A., Stefanadis C.I. Dairy products consumption is associated with decreased levels of inflammatory markers related to cardiovascular disease in apparently healthy adults: The ATTICA study. Journal of the American College of Nutrition 2010, 29:357-364.
136. Panchaud A., Affolter M., Kussmann M. Mass spectrometry for nutritional peptidomics: How to analyze food bioactives and their health effects. Journal of Proteomics 2012, 75:3546-3559.
137. Pasi A., Mahler H., Lansel N., Bernasconi C., Messiha F. beta-Casomorphin-immunoreactivity in the brain stem of the human infant. Research Communications in Chemical Pathology and Pharmacology 1993, 80:305-322.
138. Peters M.C. Strategies for noninvasive demineralized tissue repair. Dental Clinics of North America 2010, 54:507-525.
139. Picariello G., Iacomino G., Mamone G., Ferranti P., Fierro O., Gianfrani C., Di Luccia A., Addeo F. Transport across Caco-2 monolayers of peptides arising from in vitro digestion of bovine milk proteins. Food Chemistry 2013, 139:203-212.
140. Pihlanto A. Antioxidative peptides derived from milk proteins. International Dairy Journal 2006, 16:1306-1314.
141. Pinto G., Caira S., Cuollo M., Lilla S., Chianese L., Addeo F. Bioactive casein phosphopeptides in dairy products as nutraceuticals for functional foods. Milk protein 2012, 1-42. InTech. http://dx.doi.org/10.5772/50725, W.L. Hurley (Ed.).
142. Ponstein-Simarro Doorten A.Y., vd Wiel J.A.G., Jonker D. Safety evaluation of an IPP tripeptide-containing milk protein hydrolysate. Food and Chemical Toxicology 2009, 47:55-61.
143. Poppitt S.D., Strik C.M., McArdle B.H., McGill A.-T., Hall R.S. Evidence of enhanced serum amino acid profile but not appetite suppression by dietary glycomacropeptide (GMP): A comparison of dairy whey proteins. Journal of the American College of Nutrition 2013, 32:177-186.
144. Power O., Hallihan A., Jakeman P. Human insulinotropic response to oral ingestion of native and hydrolysed whey protein. Amino Acids 2009, 37:333-339.
145. Power O., Jakeman P., FitzGerald R.J. Antioxidative peptides: Enzymatic production, in vitro and in vivo antioxidant activity and potential applications of milk-derived antioxidative peptides. Amino Acids 2013, 44:797-820.
146. Prioult G., Pecquet S., Fliss S. Stimulation of interleukin-10 production by acidic β-lactoglobulin-derived peptides hydrolyzed with Lactobacillus paracasei NCC2461 peptidases. Clinical and Diagnostic Laboratory Immunology 2004, 11:266-271.
147. Qin L.-Q., Xu J.-Y., Dong J.-Y., Zhao Y., van Bladeren P., Zhang W. Lactotripeptides intake and blood pressure management: A meta-analysis of randomised controlled clinical trials. Nutrition, Metabolism, and Cardiovascular Diseases 2013, 23:395-402.
148. Quirós A., Dávalos A., Lasunción M.A., Ramos M., Recio I. Bioavailability of the antihypertensive peptide LHLPLP: Transepithelial flux of HLPLP. International Dairy Journal 2008, 18:279-286.
149. Raspopow K., Abizaid A., Matheson K., Anisman H. Anticipation of a psychosocial stressor differentially influences ghrelin, cortisol and food intake among emotional and non-emotional eaters. Appetite 2014, 74:35-43.
150. Renlund S., Erlandsson I., Hellman U., Silberring J., Wernstedt C., Lindström L., Nyberg F. Micropurification and amino acid sequence of β-casomorphin-8 in milk from a woman with postpartum psychosis. Peptides 1993, 14:1125-1132.
151. Reynolds E.C. Anticariogenic complexes of amorphous calcium phosphate stabilized by casein phosphopeptides: A review. Special Care in Dentistry 1998, 18:8-15.
152. Reynolds E.C. Calcium phosphate-based remineralization systems: Scientific evidence?. Australian Dental Journal 2008, 53:268-273.
153. Reynolds E.C., Cai F., Shen P., Walker G.D. Retention in plaque and remineralisation of enamel lesions by various forms of calcium in a mouthrinse or sugar-free chewing-gum. Journal of Dental Research 2003, 82:206-211.
154. Righard L., Carlsson-Jonsson A., Nyberg F. Enhanced levels of immunoreactive β-casomorphin-8 in milk of breastfeeding women with mastitis. Peptides 2014, 51:54-58.
155. Rocha G.A., Trindade M.A., Netto F.M., Favaro-Trindade C.S. Microcapsules of a casein hydrolysate: Production, characterization, and application in protein bars. Food Science and Technology International 2009, 15:407-413.
156. Rose R.K. Effects of an anticariogenic casein phosphopeptide on calcium diffusion in streptococcal model dental plaques. Archives of Oral Biology 2000, 45:569-575.
157. Sánchez-Rivera L., Ares I., Miralles B., Gómez-Ruiz J.Á., Recio I., Martínez-Larrañaga M.R., Anadón A., Martínez M.A. Bioavailability and kinetics of the antihypertensive casein-derived peptide HLPLP in rats. Journal of Agricultural and Food Chemistry 2014, 62:11869-11875.
158. Saadi S., Saari N., Anwar F., Hamid A.A., Ghazali H.M. Recent advances in food biopeptides: Production, biological functionalities and therapeutic applications. Biotechnology Advances 2015, 33:80-116.
159. Sam A.H., Troke R.C., Tan T.M., Bewick G.A. The role of the gut/brain axis in modulating food intake. Neuropharmacology 2012, 63:46-56.
160. 2C-mediated satiety in vivo. International Dairy Journal 2014, 38:55-64.
161. Schrezenmeir J., Jagla A. Milk and diabetes. Journal of the American College of Nutrition 2000, 19:176S-190S.
162. Shen P., Manton D.J., Cochrane N.J., Walker G.D., Yuan Y., Reynolds C., Reynolds E.C. Effect of added calcium phosphate on enamel remineralization by fluoride in a randomized controlled in situ trial. Journal of Dentistry 2011, 39:518-525.
163. Shimizu M., Tsunogai M., Arai S. Transepithelial transport of oligopeptides in the human intestinal cell, Caco-2. Peptides 1997, 18:681-687.
164. Silva V.D.M., De Marco L.M., Afonso W.D.O., Lopes D.C.F., Silvestre M.P. Comparative study of the immobilization of pancreatin and papain on activated carbon and alumina, using whey as protein substrate. World Applied Sciences Journal 2007, 2:175-183.
165. Silvestre M.P.C., Silva M.C., Silva V.D.M., Silva M.R., Amorin L.L. WPC hydrolysates obtained by the action of pancreatin: Preparation, analysis and phenylalanine removal. Asian Journal of Scientific Research 2011, 4:302-314.
166. Silvestre M.P., Silva M.C., Souza M.W., Silva V.D., Aguiar M.J., Silva M.R. Hydrolysis degree, peptide profile and phenylalanine removal from whey protein concentrate hydrolysates obtained by various proteases. International Journal of Food Science & Technology 2013, 48:588-595.
167. Soltanizadeh N., Mirmoghtadaie L. Strategies used in production of phenylalanine-free foods for PKU management. Comprehensive Reviews in Food Science and Food Safety 2014, 13:287-299.
168. Stanstrup J., Rasmussen J., Ritz C., Holmer-Jensen J., Hermansen K., Dragsted L. Intakes of whey protein hydrolysate and whole whey proteins are discriminated by LC-MS metabolomics. Metabolomics 2014, 10:719-736.
169. Stuknyte M., Cattaneo S., Masotti F., De Noni I. Occurrence and fate of ACE-inhibitor peptides in cheeses and in their digestates following in vitro static gastrointestinal digestion. Food Chemistry 2015, 168:27-33.
170. Subtil S.F., Rocha-Selmi G.A., Thomazini M., Trindade M.A., Netto F.M., Favaro-Trindade C.S. Effect of spray drying on the sensory and physical properties of hydrolysed casein using gum arabic as the carrier. Journal of Food Science and Technology 2014, 51:2014-2021.
171. Sugawara K., Takahashi H., Kashiwagura T., Yamada K., Yanagida S., Homma M., Dairiki K., Sasaki H., Kawagoshi A., Satake M. Effect of anti-inflammatory supplementation with whey peptide and exercise therapy in patients with COPD. Respiratory Medicine 2012, 106:1526-1534.
172. Sun Z., Zhang Z., Wang X., Cade R., Elmir Z., Fregly M. Relation of β-casomorphin to apnea in sudden infant death syndrome. Peptides 2003, 24:937-943.
173. Svedberg J., de Haas J., Leimenstoll G., Paul F., Teschemacher H. Demonstration of β-casomorphin immunoreactive materials in in vitro digests of bovine milk and in small intestine contents after bovine milk ingestion in adult humans. Peptides 1985, 6:825-830.
174. Teschemacher H., Koch G., Brantl V. Milk protein-derived opioid receptor ligands. Peptide Science 1997, 43:99-117.
175. Teucher B., Majsak-Newman G., Dainty J.R., McDonagh D., FitzGerald R.J., Fairweather-Tait S.J. Calcium absorption is not increased by caseinophosphopeptides. The American Journal of Clinical Nutrition 2006, 84:162-166.
176. Thomä-Worringer C., Sørensen J., López-Fandiño R. Health effects and technological features of caseinomacropeptide. International Dairy Journal 2006, 16:1324-1333.
177. Turgeon S.L., Rioux L.-E. Food matrix impact on macronutrients nutritional properties. Food Hydrocolloids 2011, 25:1915-1924.
178. Turpeinen A.M., Järvenpää S., Kautiainen H., Korpela R., Vapaatalo H. Antihypertensive effects of bioactive tripeptides-a random effects meta-analysis. Annals of Medicine 2013, 45:51-56.
179. Udenigwe C.C., Aluko R.E. Food protein-derived bioactive peptides: Production, processing, and potential health benefits. Journal of Food Science 2012, 77:R11-R24.
180. Usinger L., Ibsen H., Linneberg A., Azizi M., Flambard B., Jensen L.T. Human in vivo study of the renin-angiotensin-aldosterone system and the sympathetic activity after 8 weeks daily intake of fermented milk. Clinical Physiology and Functional Imaging 2010, 30:162-168.
181. Usinger L., Jensen L.T., Flambard B., Linneberg A., Ibsen H. The antihypertensive effect of fermented milk in individuals with prehypertension or borderline hypertension. Journal of Human Hypertension 2010, 24:678-683.
182. van der Velden W.J., van Iersel T.M., Blijlevens N.M., Donnelly J.P. Safety and tolerability of the antimicrobial peptide human lactoferrin 1-11 (hLF1-11). BMC Medicine 2009, 7:44.
183. van Loon L.J., Saris W.H., Verhagen H., Wagenmakers A.J. Plasma insulin responses after ingestion of different amino acid or protein mixtures with carbohydrate. The American Journal of Clinical Nutrition 2000, 72:96-105.
184. Vermeirssen V., Deplancke B., Tappenden K.A., Van Camp J., Gaskins H.R., Verstraete W. Intestinal transport of the lactokinin Ala-Leu-Pro-Met-His-Ile-Arg through a Caco-2 Bbe monolayer. Journal of Peptide Science 2002, 8:95-100.
185. Wada Y., Lönnerdal B. Bioactive peptides derived from human milk proteins - mechanisms of action. The Journal of Nutritional Biochemistry 2014, 25:503-514.
186. Walsh D.J., Bernard H., Murray B.A., MacDonald J., Pentzien A.K., Wright G.A., Wal J.M., Struthers A.D., Meisel H., FitzGerald R.J. In vitro generation and stability of the lactokinin β-lactoglobulin fragment (142-148). Journal of Dairy Science 2004, 87:3845-3857.
187. WHO Cardiovascular diseases (CVDs) 2013, Factsheet No. 317. Accessed in February 2015.
188. WHO Obesity and overweight, fact sheet N°311 2013, Accessed in February 2015.
189. Wilson H.L., Buchanan R.M., Allan B., Tikoo S.K. Milk-derived antimicrobial peptides to protect against Neonatal Diarrheal Disease: An alternative to antibiotics. Procedia in Vaccinology 2012, 6:21-32.
190. Xu J.-Y., Qin L.-Q., Wang P.-Y., Li W., Chang C. Effect of milk tripeptides on blood pressure: A meta-analysis of randomized controlled trials. Nutrition (Burbank, Los Angeles County, Calif.) 2008, 24:933-940.
191. Yamada A., Sakurai T., Ochi D., Mitsuyama E., Yamauchi K., Abe F. Antihypertensive effect of the bovine casein-derived peptide Met-Lys-Pro. Food Chemistry 2015, 172:441-446.
192. Yang S., Mao X.-Y., Li F.-F., Zhang D., Leng X.-J., Ren F.-Z., Teng G.-X. The improving effect of spray-drying encapsulation process on the bitter taste and stability of whey protein hydrolysate. European Food Research and Technology 2012, 235:91-97.
193. Yengopal V., Mickenautsch S. Caries preventive effect of casein phosphopeptide-amorphous calcium phosphate (CPP-ACP): A meta-analysis. Acta odontologica Scandinavica 2009, 67:321-332.
194. Yvon M., Beucher S., Guilloteau P., Le Huerou-Luron I., Corring T. Effects of caseinomacropeptide (CMP) on digestion regulation. Reproduction, Nutrition, Development 1994, 34:527-537.
195. Zambrowicz A., Timmer M., Polanowski A., Lubec G., Trziszka T. Manufacturing of peptides exhibiting biological activity. Amino Acids 2013, 44:315-320.
196. Zheng H., Shen X., Bu G., Luo Y. Effects of pH, temperature and enzyme-to-substrate ratio on the antigenicity of whey protein hydrolysates prepared by Alcalase. International Dairy Journal 2008, 18:1028-1033.